What they were paid
Caris Life Sciences Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $50,000 | $299,999 | — | — | $349,999 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Caris Life Sciences, Inc. DEF 14A filed April 23, 2026, accession 0002019410-26-000032, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Caris Life Sciences pays directors a $50,000 cash retainer and $337,061 in equity.
The rest of the Caris Life Sciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brian J. Brille | Director | $0 |
| Danny Phillips | Independent Director | $412,061 |
| David Dean Halbert | Chair of the Board | $0 |
| David Fredrickson | Independent Director | $387,061 |
| George H. Poste | Independent Director | $349,999 |
| Jeffrey Vacirca | Independent Director | $349,999 |
| Jonathan Knowles | Independent Director | $349,999 |
| Joseph E. Gilliam | Independent Director | $408,561 |
| Laura I. Johansen | Independent Director | $358,999 |
| Lloyd B. Minor | Independent Director | $349,999 |
| Peter M. Castleman | Lead Independent Director | $647,340 |
The full Caris Life Sciences compensation record
free company briefThis page is one director within Caris Life Sciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat